Lab News
Agendia, Paige partner to better breast cancer treatment
November 18, 2020 -- Genetic testing company Agendia and artificial intelligence pathology company Paige have partnered to improve planning for breast cancer treatment, with the goal of enabling faster access to genetic information for women.
November 18, 2020 -- Genetic testing company Agendia and artificial intelligence pathology company Paige have partnered to improve planning for breast cancer treatment, with the goal of enabling faster access to genetic information for women.
Northwell's SARS-CoV-2 LDT assay can test more patients at once
November 18, 2020 -- Scientists from Northwell Health Laboratories have developed a laboratory-developed test (LDT) assay that uses a different set of reagents than existing assays, allowing it to test three times as many patients for SARS-CoV-2 at one time, according to a study published in the Journal of Molecular Diagnostics.
November 18, 2020 -- Scientists from Northwell Health Laboratories have developed a laboratory-developed test (LDT) assay that uses a different set of reagents than existing assays, allowing it to test three times as many patients for SARS-CoV-2 at one time, according to a study published in the Journal of Molecular Diagnostics.
Philips deploys telepathology technology
November 17, 2020 -- Philips said that several pathology laboratories around the world have used its IntelliSite Pathology Solution to provide telediagnostics during the COVID-19 pandemic.
November 17, 2020 -- Philips said that several pathology laboratories around the world have used its IntelliSite Pathology Solution to provide telediagnostics during the COVID-19 pandemic.
Hologic wins CE Mark for cervical cancer screening system
November 17, 2020 -- Hologic has secured the CE Mark for its Genius Digital Diagnostics digital cytology platform for cervical cancer screening. The system combines a new artificial intelligence algorithm with digital imaging to aid cytotechnologists and pathologists in detecting precancerous lesions and cancer in women.
November 17, 2020 -- Hologic has secured the CE Mark for its Genius Digital Diagnostics digital cytology platform for cervical cancer screening. The system combines a new artificial intelligence algorithm with digital imaging to aid cytotechnologists and pathologists in detecting precancerous lesions and cancer in women.
Finger-prick SARS-CoV-2 test less accurate than presumed
November 12, 2020 -- The accuracy of a rapid finger-prick antibody test for SARS-CoV-2 may be much lower than previously suggested, resulting in numerous false positives, according to a new study published November 12 in the BMJ.
November 12, 2020 -- The accuracy of a rapid finger-prick antibody test for SARS-CoV-2 may be much lower than previously suggested, resulting in numerous false positives, according to a new study published November 12 in the BMJ.
Hologic gets CE Mark for breast specimen x-ray system
November 12, 2020 -- Hologic has received the CE Mark for its Faxitron Path+ specimen radiography system, which can be used for breast tissue imaging. The system consists of a high-resolution detector that allows pathologists to image specimens of various sizes.
November 12, 2020 -- Hologic has received the CE Mark for its Faxitron Path+ specimen radiography system, which can be used for breast tissue imaging. The system consists of a high-resolution detector that allows pathologists to image specimens of various sizes.
CAP, ASCP release lymphoma workup guide
November 12, 2020 -- The College of American Pathologists (CAP) and the American Society for Clinical Pathology (ASCP) have published a new guideline for the workup of lymphoma in adults. The guideline seeks to address variations in practice regarding diagnosing the disease.
November 12, 2020 -- The College of American Pathologists (CAP) and the American Society for Clinical Pathology (ASCP) have published a new guideline for the workup of lymphoma in adults. The guideline seeks to address variations in practice regarding diagnosing the disease.
Lexogen launches high-throughput SARS-CoV-2 test
November 12, 2020 -- Lexogen has released a high-throughput SARS-CoV-2 test that it says will allow for mass screening. The test identifies newly infected people even without symptoms.
November 12, 2020 -- Lexogen has released a high-throughput SARS-CoV-2 test that it says will allow for mass screening. The test identifies newly infected people even without symptoms.
Qiagen releases portable SARS-CoV-2 antigen test
November 12, 2020 -- Qiagen has launched a portable, digital SARS-CoV-2 antigen test that can analyze more than 30 swab samples per hour. The company developed the QIAreach SARS-CoV-2 antigen test in collaboration with the Australian firm Ellume.
November 12, 2020 -- Qiagen has launched a portable, digital SARS-CoV-2 antigen test that can analyze more than 30 swab samples per hour. The company developed the QIAreach SARS-CoV-2 antigen test in collaboration with the Australian firm Ellume.
Test identifies any infection from any sample in hours
November 11, 2020 -- A new rapid test can identify any infection from any type of bodily fluid in as few as six hours, possibly changing the way diseases are diagnosed and treated, according to a study published November 9 in Nature Medicine.
November 11, 2020 -- A new rapid test can identify any infection from any type of bodily fluid in as few as six hours, possibly changing the way diseases are diagnosed and treated, according to a study published November 9 in Nature Medicine.
Webinars/Videos
Case Study™
Conferences
American Association for Clinical Chemistry (AACC) Annual Scientific Meeting
December 13-17
Online
December 13-17
Online
Society for Laboratory Automation and Screening (SLAS) 2021
January 23-27, 2021
Online
January 23-27, 2021
Online
Festival of Genomics & Biodata
January 28-29, 2021
London, Greater London United Kingdom
January 28-29, 2021
London, Greater London United Kingdom
A Practical Approach to Surgical Pathology
April 23-25, 2021
Las Vegas, Nevada United States
April 23-25, 2021
Las Vegas, Nevada United States
International Molecular Pathological Epidemiology (MPE) Meeting
May 24-25, 2021
Boston, Massachusetts United States
May 24-25, 2021
Boston, Massachusetts United States
Connect
Latest Tweets